10mg
Pharmaceutical-grade GHRH analogue peptide, noted in research for its role in growth hormone regulation and reported findings related to visceral adipose tissue reduction. It stimulates endogenous growth hormone pulsatility and may increase IGF-1 levels.
Independently verified by Analiza Białek with a reported purity of 99%, with final vial content confirmed at 10.23 mg against a 10 mg label claim. Supplied as a lyophilised powder, held in UK stock with fast dispatch.
